FDA Orange Book
Generic for Onfi
Onfi contains clobazam. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Onfi is clobazam. 14 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Onfi and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Onfi products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| suspension, oral | 2.5MG/ML | Marketed (Rx) | AB | 7 | AB |
| tablet, oral | 10MG | Marketed (Rx) | AB | 10 | AB |
| tablet, oral | 20MG | Marketed (Rx) | AB | 10 | AB |
| tablet, oral | 5MG | Discontinued | None | 1 | None |
NDA 203993, 202067, held by LUNDBECK PHARMACEUTICALS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic clobazam
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AMNEAL PHARMACEUTICALS LLC | 210039 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 2.5MG/ML |
| BIONPHARMA INC | 208819 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 2.5MG/ML |
| AMNEAL PHARMACEUTICALS CO GMBH | 209718 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 10MG, 20MG |
| BIONPHARMA INC | 208825 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 10MG, 20MG |
| HETERO LABS LTD UNIT III | 209795 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 10MG, 20MG |
| PHARMAZONE | 209808 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 10MG, 20MG |
| UPSHER SMITH LABORATORIES LLC | 209687 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 10MG, 20MG |
| ZYDUS PHARMACEUTICALS USA INC | 211449 | AB (A-rated, therapeutically equivalent) | October 22, 2018 | 10MG, 20MG |
| LUPIN LTD | 210545 | AB (A-rated, therapeutically equivalent) | December 14, 2018 | 10MG, 20MG |
| MICRO LABS LTD | 211711 | AB (A-rated, therapeutically equivalent) | January 30, 2019 | 10MG, 20MG |
| TARO PHARMACEUTICAL INDUSTRIES LTD | 210978 | AB (A-rated, therapeutically equivalent) | April 15, 2019 | 2.5MG/ML |
| ALKEM LABORATORIES LTD | 212714 | AB (A-rated, therapeutically equivalent) | September 6, 2019 | 10MG, 20MG, 5MG |
| HETERO LABS LTD UNIT III | 209796 | AB (A-rated, therapeutically equivalent) | February 24, 2020 | 2.5MG/ML |
| CHARTWELL MOLECULAR HOLDINGS LLC | 213110 | AB (A-rated, therapeutically equivalent) | April 24, 2020 | 2.5MG/ML |
| ALKEM LABORATORIES LTD | 213039 | AB (A-rated, therapeutically equivalent) | May 6, 2021 | 2.5MG/ML |
| MSN LABORATORIES PRIVATE LTD | 213404 | AB (A-rated, therapeutically equivalent) | May 11, 2021 | 10MG, 20MG |
| AUROBINDO PHARMA LTD | 214404 | AB (A-rated, therapeutically equivalent) | March 24, 2022 | 2.5MG/ML |
Onfi NDC codes
Questions
Is there a generic for Onfi?
Yes. The generic name for Onfi is clobazam. 14 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Onfi?
The active ingredient in Onfi is clobazam, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Onfi and Clobazam
- What is Onfi used for?FDA label uses
- Is Onfi a controlled substance?Schedule IV
- What is Clobazam used for?FDA label uses
- Is Clobazam a controlled substance?Schedule IV
- Generic for SympazanFDA Orange Book
- Benzodiazepines listFDA drug class
- NDC 67386-313Onfi NDC record
- NDC 67386-314Onfi NDC record
- NDC 67386-315Onfi NDC record
- Schedule IV drugs listDEA schedule